Wednesday, 27 September 2017

Pacific Edge Limited

NZX : PEB

0.4700
27 Sep 17 00:19
Change:
 0.00
Open:
0.4700
High:
0.4700
Ask:
0.4800
Volume:
0
Change(%):
0.00
Prev:
0.4700
Low:
0.4700
Bid:
0.4700
Avg vol:
0
Profile
Pacific Edge is a New Zealand based biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer.
Two products have recently completed successful clinical trials, bladder cancer detection and colorectal cancer prognosis (CRC). The bladder cancer technology Cxbladder® has been released to the market in Australia and New Zealand. CRC is being readied for commercial release. Pipeline products still in development include gastric and endometrial cancers and melanoma.
Cxbladder® is a non-invasive, accurate test that enables the early detection of bladder cancer from a small volume of urine providing general practitioners and urologists with a quick, cost effective and accurate measure of the presence of the cancer and provides urologists with the opportunity to reduce their reliance on the need for invasive tests such as cystoscopy.
The Company is commercialising its products from its new diagnostic laboratory in New Zealand and plans further commercialisation in the US and Europe as a centralised diagnostic service through its own facilities or as a turn-key solution, licensed to selected partners. Pacific Edge has plans for further studies in key markets to engage leading medical and urological opinion leaders who will be vital to success in new markets.
Summary
Shares:399,704,400
Issuer:Pacific Edge Limited
Solicitor:Anderson Lloyd Caudwell Dunedin
Registry:LINK MARKET SERVICES LIMITED
Auditor:Pricewaterhouse Coopers Dunedin
Settlement:NZCDC Settlement System
Website:http://www.peblnz.com/
Fundamentals
Market Cap:$187,861,068
52 wk High:0.6000
52 wk Low:0.4300
Sector:Investment
NTA:0.0260
Address
Pacific Edge Limited
87 St David Street
Dunedin 9016
New Zealand
Latest News
Announcements
  • FY17 Cashflow Statement Reclassification

    09:56 | 27/9/17
    NZX
    FY17 Cashflow Statement Reclassification Pacific Edge Limited wishes to advise of a classification change within the FY17 Statement of Cash Flows on page 36 of the Pacific Edge more»
  • Pacific Edge 2017 Annual Meeting Results

    10:39 | 25/8/17
    NZX
    Pacific Edge 2017 Annual Meeting Results Pacific Edge held its Annual Meeting in Dunedin on 24 August 2017, updating shareholders on its strategic progress, particularly in the more»
  • Pacific Edge 2017 Annual Meeting of Shareholders

    15:09 | 24/8/17
    NZX
    Please find attached addresses by the Chairman and CEO along with the presentation for today''s meeting. End CA:00306102 For:PEB Type:MEETING Time:2017-08-24 15:09:30 more»
  • Notice of Annual Shareholders Meeting

    09:53 | 9/8/17
    NZX
    Pacific Edge Limited advises that the 2017 Annual Meeting of Shareholders will be held at 3pm on Thursday 24 August 2017 in Dunedin, New Zealand. Shareholders will also be able t more»
  • Cxbladder Test Suite Adopted by MidCentral DHB

    09:57 | 3/8/17
    NZX
    Cxbladder Test Suite Adopted by MidCentral DHB Pacific Edge Signs Agreement Extending Commercial Partnership with MidCentral District Health Board, to Encompass All Cxbladder T more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
Add a Comment
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
Global Indices
CodeLastChange
NZ507,88340.06%
COMP6,380100.15%
DJI22,284120.05%
SP5002,49700.01%
DAX12,605100.08%
FTSE7,286160.21%
NI22520,330670.33%
TWI74.460.100.14%
Currencies
CodeLastChange
EURUSD1.1790.0060.53%
NZDUSD0.72080.00530.73%
AUDUSD0.78860.00500.63%
NZDAUD0.91400.00090.10%